A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not ...

For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time vs placebo.

For patients with Parkinson's disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist ...

As one of the leading facilities for advanced neurological and Parkinson’s care in the region, King’s College Hospital Dubai ...

Oral carbidopa-levodopa formulation improves sleep in Parkinson disease, particularly addressing sleep disturbances and ...

A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with depression who experience motivational impairments ...

Significant reduction also seen in change from baseline in daily OFF times vs placebo. HealthDay News — For patients with Parkinson disease with motor fluctuations, the oral once-daily ...

Get Instant Summarized Text (Gist) Levodopa, a dopamine-enhancing medication, may improve motivation in depression linked to high inflammation. Individuals with C-reactive protein (CRP) levels ...